Michael Lichtenauer

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Prognostic relevance of serum lactate kinetics in critically ill patients

Maryna Masyuk, Bernhard Wernly, Michael Lichtenauer et al. · Intensive Care Medicine · 2018 · 160 citations

Sepsis, Serum Lactate Kinetics, Medicine +2

Blood Urea Nitrogen (BUN) is independently associated with mortality in critically ill patients admitted to ICU

Okan Arıhan, Bernhard Wernly, Michael Lichtenauer et al. · PLoS ONE · 2018 · 149 citations · Full text

Primary sources and immunological prerequisites for sST2 secretion in humans

Michael Mildner, Angela Storka, Michael Lichtenauer et al. · Cardiovascular Research · 2010 · 132 citations · Full text

The Lactate/Albumin Ratio: A Valuable Tool for Risk Stratification in Septic Patients Admitted to ICU

Michael Lichtenauer, Bernhard Wernly, Bernhard Ohnewein et al. · International Journal of Molecular Sciences · 2017 · 123 citations · Full text